Navigation Links
Infinity Bio-Energy Ltd. Announces 2008 Annual General Meeting
Date:6/16/2008

SAO PAULO, Brazil, June 17 /PRNewswire/ -- Pursuant to the BDR offering and BOVESPA Listing announcement released on June 06, 2008, Infinity Bio-Energy Ltd. has called a shareholders' meeting on June 25, 2008 at 10:00 a.m (Sao Paulo time) to approve new bye-laws conforming to Novo Mercado Standards, the election and re-election of new board directors and the presentation of auditors' reports and financial statements and other matters.

Novo Mercado is a special segment of the Brazilian Stock Exchange (BOVESPA) which requires high standards of Corporate Governance. Notwithstanding that the BDR offering does not demand the same Corporate Governance levels, the Company intends to incorporate the Novo Mercado standards, being governed by the proposed bye-laws. In order to achieve these standards, the Company invites all shareholders to vote on the 2008 Annual General Meeting.

The agenda is described below:

Notice

YOU ARE HEREBY NOTIFIED that the 2008 Annual General Meeting of the Company
will be held at Rua Funchal, 418, 22nd floor, Sao Paulo, SP, Brazil, on:

June 25, 2008 at 10:00 a.m. (Sao Paulo time)

AGENDA

1. Elect a Chairman of the General Meeting, if necessary.

2. Read Notice convening this meeting.

3. Minutes of the last General Meeting to be read and confirmed.

4. Presentation of Auditors' Report and Financial Statements for the

year ended March 31, 2008.

5. Presentation of Directors' Report to the Shareholders.

6. Appoint BDO as Auditor of the Company until the close of the next

Annual General Meeting and authorize the Board of Directors to

determine the remuneration of the Auditor.

7. Consider the election of Eduardo Bom Angelo, Alberto Mendes Tepedino

and Dimitri Marriette Henri Pauwels as Class III Directors, and

authorize them to appoint Alternate Directors as and when they deem

fit.

8. Consider the re-election of John Walter and Dominic DiMarco as Class

II Directors, and authorize them to appoint Alternate Directors as

and when they deem fit.

9. Consider to redesign Andrew Lipman and Sergio Thompson-Flores as

Class II Directors, and authorize them to appoint Alternate

Directors as and when they deem fit.

10. Consider that the fees payable to the Directors will be determined

by the Compensation Committee.

11. Consider and, if thought fit, approve the recommendation of the

Board of Directors to amend the existing Bye-Laws of the Company in

the manner specified in the blacklined version of the Bye-Laws, to

be effective upon and subject to consummation of the offer of the

Brazilian DRs.

12. Consider any other business, which may properly come before the

meeting.

The proxy and amended bye-laws have been sent to the shareholders and are also available on the Company's website at http://www.infinitybio.com.br.


'/>"/>
SOURCE Infinity Bio-Energy Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Elekta Announces Elekta Infinity - a New System for Faster and More Precise Treatment of Cancer Tumors
2. EnzySurge, Maker of DermaStream(TM), Announces the Formation of its Scientific Advisory Board
3. Haemonetics Announces Launch of Faster Plasma Collection Protocol
4. Meritage Pharma, Inc. Announces Company Formation and $22.5M Series A Financing
5. Angiotech announces market launch of Quill(TM) SRS MONODERM(TM)
6. Exelixis Announces June 19 Webcast of Presentation at the William Blair 28th Annual Growth Stock Conference
7. Villa St. Benedict Announces New Web Site
8. BioNeutral Announces a BREAKTHROUGH in the Fight Against Bioterrorism
9. Indevus Announces Management Changes
10. Chindex International, Inc. Announces Fiscal 2008 Year End and Fourth Quarter Results
11. Cell Therapeutics, Inc. Announces Issuance of 2011 Convertible Senior Notes and Common Stock Warrants to a Single Institutional Investor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/9/2016)... According to a new market research report "Oligonucleotide Synthesis Market ... (Research, PCR, Gene, DNA, NGS, Diagnostic, RNAI), End user (Academic, Pharmaceutical, ... is expected to reach USD 2.20 Billion by 2021 from USD ... forecast period. Continue Reading ... ...
(Date:12/8/2016)... ... 2016 , ... From wearable devices that can improve performance ... Thursday, December 15th a panel of entrepreneurs, innovators and a Philadelphia Eagles front ... Smart Talk session. Smart Talk will run from 8:30 – 10:30 a.m. at ...
(Date:12/8/2016)... ... December 08, 2016 , ... The ... — optogenetics — is key to exciting advances in the study and mapping ... light projected via free-space optics stimulates small, transparent organisms and excites neurons within ...
(Date:12/8/2016)... ... December 08, 2016 , ... KBioBox llc ... to client demand KbioBox developed a sophisticated “3 click” gene dditing off target ... from KBioBox’s new website, https://www.kbiobox.com/ and powered by the company’s ...
Breaking Biology Technology:
(Date:12/7/2016)... , Dec. 7, 2016   Veridium , ... the appointment of new CEO James Stickland ... with decades of experience, has served in senior ... where he specialized in expanding a pipeline of ... portfolios. He most recently served as managing director ...
(Date:12/5/2016)... , Dec. 5, 2016  The Office of ... published "Can CT Scans Enhance or Replace Medico ... potential of supporting or replacing forensic autopsies with ... scan. In response to recommendations made ... exploring using CT scans as a potential component ...
(Date:11/30/2016)... , Nov. 30, 2016  higi SH ... new partnership initiative targeting national brands, industry thought-leaders ... reward their respective audiences for taking steps to ... its inception in 2012, higi has built the ... impacting over 38 million people who have conducted ...
Breaking Biology News(10 mins):